Skip to content
healthcare.dev

Rivastigmine Tartrate

NDC 72241-014, Rivastigmine Tartrate, capsule, from Modavar Pharmaceuticals LLC.

Product NDC
72241-014
Status
Listed
Labeler
Modavar Pharmaceuticals LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203844
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72241-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE TARTRATE6 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
72241-014-037224100140360 CAPSULE in 1 BOTTLE (72241-014-03)
72241-014-1072241001410500 CAPSULE in 1 BOTTLE (72241-014-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/209f3b02-0acf-46e9-b355-91c918a20eb3
  • NADAC price for package 72241001403

    GET /v1/drugs/nadac/72241001403

Use it

Look up 72241-014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72241-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72241-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.